Efficacy And Safety Of CX516 In Elderly Participants With Mild Cognitive Impairment.

Clinical trial NCT00040443 · COMPLETED

Trial details

NCT number: NCT00040443
Sponsor: RespireRx
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Mild Cognitive Impairment

Start date: 2002-04-01
Primary completion: 2003-08-01
Enrollment: 175

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.